STAT3 and ovarian carcinoma: simulated IL-6-stimulated ovarian cancer cell proliferation, migration, and apoptosis, as well as STAT3 pathway activation processes, based on a multi-scale ovarian cancer model, and the simulation results were consistent with recent experimental evidence that STAT3 ovarian cancer cells have high levels of survival and drug resistance (47).